← Voltar às Notícias

Tags: health technology

Meta lança Muse Spark AI, permite que os usuários façam upload de dados de saúde em meio a preocupações de privacidade

Meta lança Muse Spark AI, permite que os usuários façam upload de dados de saúde em meio a preocupações de privacidade
Meta's Superintelligence Labs rolled out Muse Spark, a new generative AI model that can analyze users' personal health information, through the Meta AI app. The company says the tool was trained with input from more than 1,000 physicians and will soon appear on Facebook, Instagram and WhatsApp. Health experts warn that the service is not HIPAA‑compliant, may retain data for future training and could expose sensitive information, raising serious privacy and safety questions. Ler mais

Corti Lança Symphony AI para Transformar a Codificação Médica

Corti Lança Symphony AI para Transformar a Codificação Médica
Corti, the Copenhagen‑based health AI company, introduced Symphony for Medical Coding, an agentic system that treats coding as a reasoning task rather than simple labeling. Built on a peer‑reviewed framework and a study of 1.8 million patient encounters, Symphony claims up to 25% higher clinical accuracy than models from OpenAI, Anthropic, Amazon, Oracle and Microsoft. The system uses four sequential agents to extract evidence, navigate the ICD index, validate candidates and reconcile final codes, delivering auditable outputs linked to supporting clinical evidence. Available through an API and integrated with the Corti Console, Symphony operates across U.S. and European coding environments and aims to reduce errors that affect billing, reporting and public health data. Ler mais

DeepRare AI Supera Médicos no Diagnóstico de Doenças Raras

DeepRare AI Supera Médicos no Diagnóstico de Doenças Raras
DeepRare, an AI system that combines 40 specialized tools and a reasoned workflow, outperformed seasoned physicians in a head‑to‑head study of rare disease diagnosis. The system identified the correct disease on its first suggestion 64.4% of the time versus 54.6% for doctors, and reached 79% accuracy when offering three suggestions compared with 66% for clinicians. Physicians endorsed the AI’s reasoning 95.4% of the time. Since its July 2025 launch, more than 600 medical institutions have accessed the platform, which aims to augment—not replace—human diagnosticians and could shorten the years‑long diagnostic odyssey for millions worldwide. Ler mais

OpenAI Lança Recurso de Saúde do ChatGPT com Salvaguardas Aumentadas

OpenAI Lança Recurso de Saúde do ChatGPT com Salvaguardas Aumentadas
OpenAI has introduced ChatGPT Health, a dedicated health‑focused tab within the ChatGPT app that offers users a safer way to ask medical questions, review lab results, and organize health information. The feature uses the same large language model as standard ChatGPT but adds stricter limits, physician‑reviewed responses, and extra encryption to protect sensitive data. It can sync with apps such as Apple Health and upload documents, yet it does not replace professional diagnosis or treatment. OpenAI stresses that the tool is for consumer wellness and is not HIPAA‑covered, while acknowledging ongoing risks like hallucinations and the need for user caution. Ler mais

Fundadores da Fitbit Lançam Luffu, uma Plataforma de Saúde Familiar com Inteligência Artificial

Fundadores da Fitbit Lançam Luffu, uma Plataforma de Saúde Familiar com Inteligência Artificial
James Park and Eric Friedman, the co‑founders of Fitbit, have introduced Luffu, an intelligent family‑care system that aggregates health data from wearables, Apple Health, Fitbit, and user‑entered inputs. The platform uses artificial intelligence to organize information, answer personalized health questions, and issue proactive alerts for medication adherence and potential health issues. Currently in private testing, Luffu will launch as a mobile app with plans to add complementary hardware devices. Ler mais

OpenAI Visa Prática de Adoção de IA em 2026, Expande Infraestrutura e Novos Modelos de Receita

OpenAI Visa Prática de Adoção de IA em 2026, Expande Infraestrutura e Novos Modelos de Receita
OpenAI’s 2026 strategy, outlined by CFO Sarah Friar, centers on practical AI adoption across health, science, and enterprise. The company is investing heavily in infrastructure—about $1.4 trillion in commitments as of November—and aims to close the gap between AI capabilities and real‑world use. User metrics are at all‑time highs, driven by a flywheel of compute, research, products, and monetization. New initiatives include advertising, the worldwide ChatGPT Go subscription, and emerging business models such as licensing, IP agreements, and outcome‑based pricing. OpenAI also hints at hardware devices developed with designer Jony Ive. Ler mais

OpenAI Lança ChatGPT Saúde, um Assistente de Saúde de IA Dedicado

OpenAI Lança ChatGPT Saúde, um Assistente de Saúde de IA Dedicado
OpenAI announced a new feature called ChatGPT Health, creating a separate space for users to discuss health and wellness topics with the AI. The company says more than 230 million users ask health‑related questions each week, and the new product isolates those conversations from regular chats to protect context and privacy. ChatGPT Health can integrate data from popular wellness apps such as Apple Health, Function, and MyFitnessPal, but OpenAI stresses that health chats will not be used to train its models. The rollout is expected in the coming weeks. Ler mais

OpenAI Lança ChatGPT Saúde, um Portal de Saúde AI Dedicado

OpenAI Lança ChatGPT Saúde, um Portal de Saúde AI Dedicado
OpenAI has introduced ChatGPT Health, a separate space within its AI chatbot that lets users link medical records and wellness apps for more personalized health‑related answers. The company says the feature includes extra privacy safeguards and that conversations in this area will not be used to train its foundational models. Still in testing, the service has regional limits on which health apps can connect. OpenAI stresses that ChatGPT Health is not meant for diagnosis or treatment and warns that AI chatbots are not qualified to give medical advice, citing risks of inaccurate information and privacy concerns. Ler mais

OpenAI Relata 40 Milhões de Usuários Diários do ChatGPT Buscando Respostas de Saúde

OpenAI Relata 40 Milhões de Usuários Diários do ChatGPT Buscando Respostas de Saúde
OpenAI says that 40 million people ask health‑related questions of ChatGPT each day, representing more than five percent of all prompts. A survey of U.S. adults who have used AI for health in the past three months shows that over half use the tool to explore symptoms, while many also rely on it for medical terminology and treatment options. OpenAI describes the chatbot as a "healthcare ally" and cites a real‑world case where a user helped coordinate urgent care for a family member abroad. The company acknowledges the risks of relying on AI for medical advice and says it is partnering with hospitals and researchers to improve safety and accuracy. Ler mais

Apple Planeja Chatbot de Saúde com Inteligência Artificial para Assinatura Health+

Apple Planeja Chatbot de Saúde com Inteligência Artificial para Assinatura Health+
Apple is reportedly developing an artificial‑intelligence health chatbot that would be integrated into a new Health+ subscription service. The chatbot is intended to help users interpret and manage their health data, positioning Apple against competitors that already bundle AI assistants with fitness wearables. While the feature could enhance Apple’s health ecosystem, analysts warn it must deliver tangible value beyond existing tools or risk being seen as unnecessary bloat. Ler mais

Apple Watch Series 11 Recebe Aprovação da FDA para Alertas de Hipertensão

Apple Watch Series 11 Recebe Aprovação da FDA para Alertas de Hipertensão
Apple’s latest smartwatch, the Series 11, has received FDA approval for a new hypertension‑alert feature. The function uses the watch’s optical heart sensor combined with a machine‑learning algorithm trained on a study of more than 100,000 participants. It monitors users for a month‑long period to detect patterns that may indicate high blood pressure, then notifies them of a possible risk. Apple says the feature will roll out in 150 countries when the Series 11 and Ultra 3 launch on September 19. The approval follows earlier FDA clearances for Apple’s OTC hearing‑aid capability and sleep‑apnea detection, even as the company faces a lawsuit over its blood‑oxygen sensor redesign. Ler mais

Apple Apresenta Novos Apple Watch Series 11, Ultra 3, SE 3 e AirPods Pro 3 com Recursos de Saúde Expandidos

Apple Apresenta Novos Apple Watch Series 11, Ultra 3, SE 3 e AirPods Pro 3 com Recursos de Saúde Expandidos
Apple introduced a refreshed lineup of wearables, adding the Apple Watch Series 11, Apple Watch Ultra 3, Apple Watch SE 3 and AirPods Pro 3. All devices feature 5G connectivity, new health‑focused sensors such as Hypertension detection and Sleep Score, and upgraded battery life. The Series 11 offers a custom ceramic coating, 24‑hour battery life and new watch faces. The Ultra 3 adds a wider OLED display, 42‑hour battery life and satellite connectivity. The SE 3 brings core Apple Watch functionality at a lower price, while the AirPods Pro 3 include heart‑rate sensing for workouts. Together, the launch signals Apple’s continued push into integrated fitness and wellness technology. Ler mais

IA preparada para transformar a saúde por meio do aumento da eficiência e redução de custos

IA preparada para transformar a saúde por meio do aumento da eficiência e redução de custos
Artificial intelligence tools are being positioned to reshape the healthcare system by shifting care from a reactive model to proactive prevention, early detection, and streamlined operations. AI‑driven image analysis, predictive algorithms, and chat‑based triage can catch diseases earlier, guide patients to the right pathways, and free clinicians to focus on complex cases. Experts emphasize the need for specialist AI agents, hybrid human‑AI workflows, and rigorous safety monitoring to ensure accurate, trustworthy outcomes while reducing overall costs. Ler mais